ブリナツモマブ(遺伝子組換え)
Blinatumomab (Genetical Recombination)
ブリナツモマブは,遺伝子組換え一本鎖抗体(scFv-scFv)であり,1-111番目はマウス抗ヒトCD19モノクローナル抗体のL鎖の可変領域,127-250番目はマウス抗ヒトCD19モノクローナル抗体のH鎖の可変領域,256-374番目はマウス抗ヒトCD3モノクローナル抗体のH鎖の可変領域,393-498番目はマウス抗ヒトCD3モノクローナル抗体のL鎖の可変領域からなる.ブリナツモマブは,504個のアミノ酸残基からなるタンパク質である.
Blinatumomab is a recombinant single-chain antibody (scFv-scFv) composed of variable regions of an L-chain derived from mouse anti-human CD19 monoclonal antibody at positions 1-111, an H-chain derived from mouse anti-human CD19 monoclonal antibody at positions 127-250, an H-chain of mouse anti-human CD3 monoclonal antibody at positions 256-374, and an L-chain derived from mouse anti-human CD3 monoclonal antibody at positions 393-498. Blinatumomab is a protein consisting of 504 amino acid residues.
C2367H3577N649O772S19 : 5408585.00
[853426-35-4]
|